Cargando…
Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy
Introduction: Small-cell-lung-cancer (SCLC) has the worst prognosis of all lung cancers because of a high incidence of relapse after therapy. While lung cancer is the second most common malignancy in the US, only about 10% of cases of lung cancer are SCLC, therefore, it is categorized as a rare and...
Autores principales: | Sen, Chandani, Koloff, Caroline R., Kundu, Souvik, Wilkinson, Dan C., Yang, Juliette M., Shia, David W., Meneses, Luisa K., Rickabaugh, Tammy M., Gomperts, Brigitte N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441219/ https://www.ncbi.nlm.nih.gov/pubmed/37608896 http://dx.doi.org/10.3389/fphar.2023.1211026 |
Ejemplares similares
-
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response
por: Purkayastha, Arunima, et al.
Publicado: (2020) -
Targeting PEA3 transcription factors to mitigate small cell lung cancer progression
por: Shia, David W., et al.
Publicado: (2022) -
High-Throughput Drug Screening Identifies a Potent Wnt Inhibitor that Promotes Airway Basal Stem Cell Homeostasis
por: Aros, Cody J., et al.
Publicado: (2020) -
Modeling and Targeting Alzheimer’s Disease With Organoids
por: Papaspyropoulos, Angelos, et al.
Publicado: (2020) -
Open questions in human lung organoid research
por: Hughes, Tessa, et al.
Publicado: (2023)